Abstract Obesity, characterized by excessive body fat accumulation, is a growing global health concern with significant implications for both metabolic and skeletal health
[1] It functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist
Understanding your benefits is the first step to figuring out if these medications are an option for you
Some people start with Wegovy, see good results, then switch to Zepbound if they plateau or want to maximize weight loss
We performed a stepwise linear regression analysis for each group separately, and for all 41 participants, with age, sex, BMI, HbA 1c , and difference of temperature between cold and hot OGTTs as independent variables
PMID: 41823054 Panou T et al